All news on the topic: Chris Beauchamp

439
AstraZeneca explores takeover of Bristol Myers Squibb in potential $400bn deal
Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.
790
Defence stocks gain £4bn after John Healey becomes chancellor in Burnham government
Britain’s biggest defence companies have seen a £4bn boost to their value since the surprise appointment of John Healey as chancellor.